A 510(k) is a premarket submission made to FDA to demonstrate that the device to be marketed is at least as safe and effective, that is, “substantially equivalent”, to a marketed device. For devices that are low to moderate risk but are found to be “not substantially equivalent” to a predicate device, the de novo classification process provides a possible route to market.